How does preoperative fasting affect the success rate of magnetic resonance imaging in sedated infants?
Not Applicable
Active, not recruiting
- Conditions
- Infants undergoing MRI scanning with dexmedetomidine sedationNot Applicable
- Registration Number
- ISRCTN14074587
- Lead Sponsor
- ppsala University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Infants planned for an MRI scan
Exclusion Criteria
1. Age < 3 months
2. Age > 36 months
3. Gastro-esophageal reflux disease
4. Respiratory disease such as bronchopulmonary dysplasia, requiring oxygen therapy or CPAP
5. Congenital heart disease with cyanosis or myocardial dysfunction
6. MRI protocol planned duration > 45 minutes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MRI scan outcome (with or without movement artefacts) when the patient is moved from the MRI suite after the scanning procedure
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the impact of preoperative fasting duration on MRI quality in infants sedated with dexmedetomidine?
How does dexmedetomidine compare to other sedatives for reducing infant MRI motion artifacts?
Are there biomarkers that predict sedation success in infants using alpha-2 adrenergic agonists like dexmedetomidine?
What adverse events are associated with dexmedetomidine sedation in neonatal MRI procedures?
How do alternative sedation protocols affect the safety and efficacy of pediatric neuroimaging?